⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ZBH

Zimmer Biomet Holdings, Inc.

Healthcare · Medical Devices

94.61USD

+0.3900 (+0.41%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.88▲$1.88127
Next quarter$2.49▼$2.5415
Current year$8.53▲$8.47221
Next year$9.07▲$8.99195

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$2.01$2.07+0.06 (+3.0%)
2026-03-31$1.86$2.09+0.23 (+12.2%)
2025-12-31$2.4$2.42+0.02 (+0.9%)
2025-09-30$1.87$1.9+0.03 (+1.8%)

Wall Street coverage

389 ratings from 44 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Canaccord GenuityMaintainedHold$83 $100Aug 10, 2026
Truist SecuritiesMaintainedHold$92 $106Aug 7, 2026
RBC CapitalMaintainedOutperform$101 $110Aug 6, 2026
BernsteinMaintainedMarket Perform$91 $93Aug 6, 2026
StifelMaintainedBuy$105 $110Aug 6, 2026
BMO CapitalInitiated from OutperformMarket Perform$95Jul 9, 2026
Evercore ISI GroupMaintainedOutperform$120 $110Jul 6, 2026
CitigroupMaintainedNeutral$95 $93May 28, 2026
JP MorganMaintainedNeutral$100 $95Apr 29, 2026
CitigroupMaintainedNeutral$98 $95Apr 29, 2026
CitizensMaintainedMarket Outperform$120 $105Apr 29, 2026
Wells FargoMaintainedEqual-Weight$98 $90Apr 29, 2026
BarclaysMaintainedUnderweight$100 $94Apr 29, 2026
Truist SecuritiesReiteratedHold$98 $92Apr 29, 2026
StifelMaintainedBuy$110 $105Apr 29, 2026
Leerink PartnersInitiatedMarket Perform$101Apr 13, 2026
BTIGDowngraded from BuyNeutral—Mar 23, 2026
BarclaysMaintainedUnderweight$104 $100Feb 12, 2026
CitigroupMaintainedNeutral$94 $98Feb 11, 2026
Wells FargoMaintainedEqual-Weight$93 $98Feb 11, 2026
BTIGReiteratedBuy$112Feb 10, 2026
NeedhamReiteratedHold—Feb 10, 2026
UBSMaintainedSell$88 $86Jan 28, 2026
BernsteinMaintainedMarket Perform$97 $99Jan 9, 2026
BTIGReiteratedBuy$112Jan 8, 2026

Insider transactions

64 filings from 12 insiders · 9 buy / 2 sell over 6m

Officers and directors of ZBH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Phipps Chad FOfficer, See remarks below.Sell3.0k$98.35$295kSep 4, 2026
THORNAL KEVIN ROfficerOther10.0k——Jul 31, 2026
YI SANGOfficerSell5.0k$82.64$413kMay 29, 2026
NOOR JEHANZEBOfficerOther6.6k——Apr 1, 2026
WINKLER LORIOfficerSell2.6k$94.66$251kMar 12, 2026
PHIPPS CHAD FOfficerOther6.8k——Mar 6, 2026
WINKLER LORIOfficerOther5.6k——Mar 6, 2026
TORNOS IVANChief Executive OfficerOther34.7k——Mar 6, 2026
UPADHYAY SUKETU PChief Financial OfficerOther14.8k——Mar 6, 2026
STELLATO PAUL AOfficerOther2.0k——Mar 6, 2026
YI SANGOfficerOther9.4k——Mar 6, 2026
VAN ZUILEN WILFREDOfficerOther7.0k——Mar 6, 2026
PHIPPS CHAD FOfficerOther2.6k——Feb 25, 2026
WINKLER LORIOfficerOther2.3k——Feb 25, 2026
TORNOS IVANChief Executive OfficerOther19.1k——Feb 25, 2026
UPADHYAY SUKETU PChief Financial OfficerOther6.4k——Feb 25, 2026
STELLATO PAUL AOfficerOther820——Feb 25, 2026
YI SANGOfficerOther2.8k——Feb 25, 2026
VAN ZUILEN WILFREDOfficerOther3.2k——Feb 25, 2026
PHIPPS CHAD FOfficerOther2.2k——Feb 20, 2026

Analyst Notes

Sign in to write

No analyst notes on ZBH yet.

Analyst Ratings

21 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current361800Hold2.56
1 mo ago361800Hold2.56
2 mo ago361800Hold2.56
3 mo ago261710Hold2.65
Price target$107.57$93.00 – $130.00
+13.7% to target